About Us

"Wockhardt has embarked on a new and exciting phase of its growth journey. As a global healthcare company, Wockhardt has proved its technical excellence by developing patented modified release formulations and other complex and challenging medical technologies. We are committed to the pursuit of excellence in business and in society."

Dr. Murtaza Khorakiwala
Managing Director,
Wockhardt Limited

The award is accompanied with a certificate allowing Wockhardt to use the trademark `BEST ENTERPRISE’ for marketing purposes.

Seen here (L-R) Wil Goodheer, President of the International Club of Rector, Dr. Murtaza Khorakiwala, Managing Director, Wockhardt

and Leticia Goodheer, Vice President of the Europe Business Assembly.

Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals.

Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 8600 Wockhardt Associates from 21 different nationalities globally. It has 3 research centres and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines.

New Wockhardt. New way oF thinking,

Wockhardt is a business in transition. New and innovative business models are in motion to make the most of emerging opportunities. A new drive for growth today permeates every mind-set, process and techno-innovation within Wockhardt.

At Wockhardt, we are looking at new ways of thinking, new ways of working and new ways to touch people’s lives.

Building A new Wockhardt

Wockhardt’s Founder Chairman and Group CEO, Dr. Habil Khorakiwala says, “A decade ago, I saw a changing world that I believed would present us with large-scale future opportunities in the field of pharmaceuticals and biotechnology. We steered our business model to leverage our research capabilities in providing innovative solutions and by constantly upgrading our world-class manufacturing facilities. We ventured outside India systematically and positioned ourselves mainly in the European and the US markets, which currently generates over 76% of our revenues.”

Growing Presence Around The World

Headquatered in Mumbai, India, Wockhardt has full-fledged operations in the USA, UK, Ireland and France. It also has its marketing presence in emerging markets of Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait.

Spearheading Research & Development

Wockhardt’s core business is innovation. It uses science and technology to develop medicines and other products that improve the quality of millions people’s lives through better health.

Wockhardt has proved its technical excellence by developing patented modified release formulations and recombinant biotechnology products. It has a multi-disciplinary R&D programme with more than 607 scientists, including over 80 doctorates, in the areas of:

Pharmaceutical Research
Biotechnology & Genomics Research
Novel Drug Delivery Systems
New Drug Discovery Programme. API Research

Chairman's Message

Dr. Habil Khorakiwala
A keen disciple of ‘Change Management’, Dr. Habil Khorakiwala has single-mindedly steered Wockhardt in becoming the first true healthcare group from India. His visionary and astute leadership resulted in Wockhardt emerging as a leading pharmaceutical and biotech conglomerate, driven by research and strategic thinking on a global scale.

Dr. Habil Khorakiwala is the Founder Chairman & Group CEO of Wockhardt Limited, a company he founded in the early 1960s. He holds a Masters in Pharmaceutical Science from Purdue University, and has participated in an Advanced Management Programme at Harvard Business School, USA. He is also the recipient of an honorary doctorate from Purdue University, USA.

Management style

Dr. Habil Khorakiwala strongly advocates that the only way towards fast growth is to be 'Customer Focussed'. This customer-centric approach has filtered down to every decision and action in Wockhardt.

His signature style is much evident in the management processes at Wockhardt i.e. open culture, participative management practices, innovations, continuous improvement, speedy response, empowerment and enjoying one’s job - are all hallmarks of Wockhardt's culture.

Industry-level participation
- Past President of FICCI (Federation of Indian Chambers of Commerce & Industry).
- Past President of the Indian Pharmaceutical Alliance (IPA), the organisation of research-based pharmaceutical companies in India.
Government Of India Nominations
- Member of the National Manufacturing Competitiveness Council set up by Dr. Manmohan Singh, Prime Minister of India
- Nominated by Govt. of India to the National Managing Committee, Indian Red Cross Society
- Nominated by the Prime Minister of India to the Advisory Board of CSIR [Council of Scientific and Industrial Research] in New Delhi
- Member of BOT (Board of Trade) instituted by the Government of India under the Ministry of Commerce & Industry
- Nominated by the Government of India as member of the Board of Directors of NIPER (National Institute of Pharmaceutical Education and Research)
Accolades Conferred
- Shiromani Vikas award for ‘Outstanding and Inspiring Contribution towards National Development’ at the hands of Mother Teresa in 1992
- Institute of Marketing & Management (IMM) ‘Top CEO’ in 2002
- International Medical Integration Council ‘Life Time Achievement’ in 2003
- Giants award for ‘Outstanding Contribution to Business and Industry’ in 2003
- Rotary Award for Vocational Excellence, 2003-04
- Ernst & Young ‘Entrepreneur of the Year’ in the Healthcare and Life Sciences’ category in 2004
- Named ‘India’s Greatest Brand Builders’ in a book authored by Dr. R L Bhatia of Centre for Change Management in 2005
- Indian Express Group of Newspapers ‘Lifetime Achievement Award’ at the Pharma Excellence Awards 2006
- UK Trade & Investment ‘Entrepreneur of the Year’ at the India Business Awards 2008
- Purdue University conferred an ‘Honorary Doctorate in Pharmacy’ in 2010
- Frost & Sullivan 'Lifetime Achievement Awards' India Healthcare Excellence Awards
International Honour

Dr. Khorakiwala has served as Honorary Consul General of Sweden in Mumbai. Top

Board of Directors

Dr. Habil Khorakiwala
Founder Chairman

Dr. Habil Khorakiwala founded Wockhardt in 1967. Today, the Wockhardt Group is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology, Active Pharmaceutical Ingredients (APIs) and Super Speciality Hospitals. An alumnus of Purdue University and Harvard Business School, he is the only non-American in the 125-year history of Purdue University to be awarded an Honorary Doctorate, the highest award that they bestow.

A member of the World Economic Forum, Dr. Khorakiwala has held many senior positions as industry representative, and has been lauded and awarded by various institutions and organisations. As a former president of FICCI (Federation of Indian Chambers of Commerce & Industry), he has met and shared India’s business and economic dynamics with many Presidents, Prime Ministers and Heads-of-State.

He is currently the Chairman of the Board of Governors at the Centre for Organisation Development in Hyderabad, a non-profit, scientific and industrial research organization and a recognized doctoral research centre. He is also the Chancellor of Jamia Hamdard University, New Delhi, which has emerged as an outstanding institution of higher learning with distinct and focused academic programmes.

Dr. Huzaifa Khorakiwala
Executive Director

Dr. Huzaifa Khorakiwala is a Bachelor of Commerce graduate from Mumbai University. He holds a master’s degree in Business Management from Yale University School of Management, USA. He joined the Company in July 1996 and has
over the years run various Wockhardt businesses and served in Corporate Administration. He is the Executive Director of the Company since April 2009.

Dr. Huzaifa Khorakiwala devotes a significant part of his time to Wockhardt’s corporate social responsibility activities. He serves as CEO of Wockhardt Foundation.

Dr. Murtaza Khorakiwala
Managing Director

Dr. Murtaza Khorakiwala represents a unique blend of scientific knowledge and business acumen. A graduate in Medicine from GS Medical College, Mumbai, India, and Master in Business Administration (MBA) from the University of Illinois, USA, he has been Managing Director of Wockhardt Limited since April 2009.

Thinking out of the box, challenging assumptions and innovation are some of the key principles that shape his strategic thought process. His young and dynamic leadership has become the ideal springboard for various corporate initiatives in creating a new Wockhardt.

A member of the executive committee of the Indian Pharmaceutical Association (IPA), he was the past Chairman of the Marketing Committee of the Bombay Management Association.

Mr. Shekhar Datta
Non-Executive Independent Director

Mr. Shekhar Datta has been a director of the Company since 2000. A mechanical engineering graduate, Mr. Datta has served as Managing Director of Greaves Cotton Limited, Chairman of Bombay Stock Exchange, and held directorships of Crompton Greaves Limited, Industrial Development Bank of India Limited, and other corporates. Mr. Datta is former member of the International Business Advisory Board of UNIDO, former president of the Confederation of Indian Industry (CII), Bombay Chamber of Commerce & Industry, and Indo-Italian Chamber of Commerce & Industry.

Mr. Aman Mehta
Non-Executive Independent Director

Mr. Aman Mehta has been a director of the Company since 2004. An Economics graduate, he has over 35 years of experience in various positions with the HSBC Group. He headed HSBC operations in the Middle East, America, Australia and Asia Pacific.

Terms & Conditions

Please read and review these Terms of Use Agreement carefully before accessing or using this website. If you proceed to access or use this website, you are agreeing to abide by these terms of use, without any limitations. You may not access or use this website if you do not agree to these terms of use. Wockhardt and its affiliate companies (hereinafter referred to as “Wockhardt”) reserve the right to add, remove or modify this information at any time without any prior notification.

The information provided in this website is for general and/or educational purpose only. For information on a specific medicine or for answers to your own particular health concerns, you should always consult with your doctor or health care professional for their professional advice.
Information on this website concerning products approved for marketing is subject to the full prescribing information for such products. Wockhardt does not recommend use of its products in a manner inconsistent with product labeling. Please check with your doctor or health care professional prior to taking any medications discussed within this website.
While Wockhardt makes reasonable efforts to make sure that the information contained in this website is accurate, Wockhardt cannot guarantee the accuracy or completeness of such information. Wockhardt provides, and you agree to use, this information on an “AS IS” basis and on an “AS AVAILABLE” basis. Wockhardt makes no representations or warranties of any kind or nature with respect to this website or its contents and disclaims all representations and warranties, whether express or implied, created by law, contract or otherwise, including, without limitation, any warranties of merchantability, fitness for a particular purpose, title or non-infringement. In no event shall Wockhardt be liable for any damages of any kind or nature, including, without limitation, direct, indirect, special (including loss of profit), consequential or incidental damages arising from, or in connection with; the existence, access to, use of or inability to use this website; or from any materials, information, qualification or recommendations appearing in this website, regardless of whether Wockhardt has been advised as to the possibility of such damages. This limitation includes damage to, or for any viruses that infect, you computer equipment.
You agree to indemnify and hold harmless Wockhardt and its employees, including without limitation, its directors, officers, agents and/or suppliers from damages, losses, costs, expenses including legal fees, resulting from you using this website and/or the information contained herein.
The website and/or information contained herein is intended for use only by the patients, customers and health care professionals who are residents of India. Other countries may have laws, regulatory requirements and medical practices that differ from those in India. Wockhardt, therefore, advises the user that the information contained herein may not be appropriate for the users who are not residents of India.
Any information received from user of this website including but not limited to, comments, questions, feedback, data, suggestions, ideas and alike is and will be deemed non-confidential. Wockhardt shall have no obligation of any kind with respect to such information and shall be free to use, reproduce, disclose and/or redistribute to others without limitation or use such information, including but not limited to ideas, concepts, know-how for the purpose of, including but not limited to, manufacturing, developing, marketing and/or advertising any products incorporating such information, either partly or wholly.

Contact Wockhardt Limited

Mobile Number*

+91

Other Information

Other categories from this seller

Tablet (26)

Cefiwok O Tablet

Call Now+918045729158,3818

Caviter Forte Tablet

Call Now+918045729158,3818

Dilex OD Tablet

Syrup (4)

Bro-Zedex Syrup

Brozedex Pet Syrup

Bro-Zedex SF Syrup

Vial (5)

Biovac Typhoid Vial

Decdan Vial

Biovac-A Vial

Gel (4)

Depiwhite Eye Contour Gel

B-Lift Eye Contour Gel

Bio-Corneum Gel

Pens (4)

Glaritus Pen Royale

Call Now+918045729158,3818

Wosulin Pen Royale

Call Now+918045729158,3818

Glaritus Dispopen

Call Now+918045729158,3818

Cream (3)

B-Lift Rich Lifting Gel Cream

Eclospan Cream

Depiwhite Cream

Capsule (3)

Buta Proxyvon Capsule

Femix Herbal Capsule

Fluproxy Capsule

Suspension (2)

Aziwok Suspension

Cefiwok Redimix Suspension

Injection (2)

Dicloaqua Injection

Feroject Inj Injection

Lotion (1)

B-Lift Active Lifting Gel Lotion

Masque (1)

Depiwhite Masque

View All Categories

GST Registration Date	01-07-2017
GST Legal status	Limited Company
GST Nature of business	Manufacturer
GST Turnover	> 500 Cr
GST Additional NOB	Office / Sale Office,Recipient of Goods or Services,Service Provision,Others,Supplier of Services,Export,Warehouse / Depot
Import Export Code (IEC)	0388084685
GST No.	27AAACW2472M1ZZ
CIN No.	L24230MH1999PLC120720